IGC Pharma Stock Forum

$IGC Pharma (IGC.US)$
IGC Pharma Advances IGC-AD1 as a Potential Alzheimer's Therapy Addressing Cognitive Impairment and Underlying Disease Pathology
Monday, 2nd December at 8:30 am
New trials to evaluate IGC-AD1's potential impact on amyloid plaque, tau tangles, and cognitive decline in Alzheimer's disease
Expanded research positions IGC-AD1 as a potential treatment targeting the underlying disease pathology of Alzheimer's
POTOMAC, MARYLAND / ACCESSWIRE / December 2, 2024 / IGC Pharma, Inc....

$IGC Pharma (IGC.US)$ $GrowGeneration (GRWG.US)$ $Flora Growth (FLGC.US)$ $Canopy Growth (CGC.US)$ $Tilray Brands (TLRY.US)$ DEA Says Formal Hearing Proceedings Regarding Proposed Rescheduling Of Marijuana Will Begin On Dec 2 At 9:30 A.m. ET

$IGC Pharma (IGC.US)$ $Tilray Brands (TLRY.US)$ $Akanda (AKAN.US)$ $Flora Growth (FLGC.US)$ $GrowGeneration (GRWG.US)$ 'Federal Health Officials 'Rejected' DEA's Request To Testify At Marijuana Rescheduling Hearing, Agency Tells Judge' - Marijuana Moment
Benzinga· 11 mins ago

$IGC Pharma (IGC.US)$ $Akanda (AKAN.US)$ $Flora Growth (FLGC.US)$ $Canopy Growth (CGC.US)$ $Tilray Brands (TLRY.US)$ Tom Angell Says "DEA Says It Is in the Process of Preparing Public Access to the Cannabis Rescheduling Proceedings Docket. For Now, Read Marijuana Moment's Coverage of the Latest Significant Filings:", 'DEA And Anti-Marijuana Group Deny Allegations They Conspired During Rescheduling Process' - Marijuana Moment
The Drug Enforcement Administration (DEA) and the proh...

$IGC Pharma (IGC.US)$
IGC Pharma Announces Additional Phase 2 Interim Results Highlighting Cognitive Benefits of IGC-AD1 for Alzheimer's Treatment
Interim results indicate cognitive improvement in the active treatment group compared to placebo
- No serious adverse events or deaths reported in the trial
IGC Pharma, Inc. (NYSE:IGC) ("IGC Pharma" or the "Company") today announced additional interim data from its ongoing Phase 2 clinical trial evaluating IGC-AD1. The trial focuses on agitation in...

$IGC Pharma (IGC.US)$ Reuters· 4 mins ago
IGC Pharma Announces Additional Phase 2 Interim Results Highlighting Cognitive Benefits of IGC-AD1 for Alzheimer's Treatment

$IGC Pharma (IGC.US)$ $Canopy Growth (CGC.US)$ $Aurora Cannabis (ACB.US)$ $Cronos Group (CRON.US)$ $GrowGeneration (GRWG.US)$
Legislative Committee In Ireland Calls For Marijuana Legalization And Decriminalization Of 'All Illicit Drugs'" - Marijuana Moment
Benzinga· 2 mins ago
After lawmakers in Ireland delayed a vote on marijuana legalization earlier this year in favor of further studying the issue, a special legislative committee on drug policy has published an interim report with nearly 60 re...

$IGC Pharma (IGC.US)$
IGC Pharma Announces Patient Enrollment at Toronto's Baycrest in Phase 2 Trial Investigating IGC-AD1
IGC Pharma (NYSE American:IGC) has announced the enrollment of patients at Baycrest Academy for Research and Education in Toronto, Canada, for its ongoing Phase 2 trial of IGC-AD1, a treatment for agitation in Alzheimer's dementia. IGC-AD1 is a partial CB1 receptor agonist with anti-neuroinflammatory properties, targeting key pathways involved in Alzheimer's disease patho...

$IGC Pharma (IGC.US)$ com boy move🚀🚀🚀

$IGC Pharma (IGC.US)$ Alzheimar Pm play.